NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAAA E-092-2006-0-US-07 Ketone Bodies And Ketone Body Esters As Blood Lipid Lowering Agents US National Stage 12/811,648 9211275 Issued PDF
NIAAA E-092-2006-0-AU-03 Ketone bodies and ketone body esters as blood lipid lowering agents AU National Stage 2009204370 Issued
NIAAA E-092-2006-0-PCT-02 Ketone bodies and ketone body esters as blood lipid lowering agents PCT PCT PCT/US2009/030095 Expired
NIAAA E-092-2006-0-CN-04 Ketone bodies and ketone body esters as blood lipid lowering agents CN National Stage 200980104958.2 Abandoned
NCI E-287-2009-1-US-01 Antiproliferative Factors And Methods Of Use US 61/142,407 Abandoned
NIA E-016-2009-0-US-01 Design And Generation Of Membrane-targeting And Epitope-tagging Module For Subcloning And Expression Ofmammalian Membrane Proteins US 61/142,531 Abandoned
NHLBI E-209-2007-0-PCT-02 Active 0.035" Guidewire With Two Separate Channels PCT PCT PCT/US2008/088655 Expired
NIAID E-205-2008-0-US-01 Sand Fly Salivary Proteins (LJM04, LJM11, LJM26, LJL143, And LJMI9) Which Have Anti-complement Activity And May Be Used To Treat Complement-related Diseases, And Also As Potential Leishimania Vaccine Candidates US 61/142,098 Abandoned
NIAID E-204-2008-0-US-01 LJL143 Sand Fly Salivary Protein, A Novel Factor Xa Inhibitor US 61/142,107 Abandoned
NCI E-064-2008-2-JP-05 Epoxy-guaiane Derivatives and Treatment of Cancer JP National Stage 2010-541518 Issued
NCI E-064-2008-2-AU-02 Epoxy-guaiane Derivatives And Treatment Of Cancer AU National Stage 2008347299 Issued
NIA E-243-2005-0-US-03 Susceptibility-Matched Multi-well Sample Holders For High-Throughput Screening by Magnetic Analysis US ORD 12/083,501 8427160 Abandoned PDF
NCI E-175-2002-0-US-03 METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL DONORS US CON 12/346,694 8268890 Expired PDF
NCI E-064-2008-2-EP-04 Epoxy-Guaiane Derivatives And Treatment of Cancer EP National Stage 08869946.7 Issued
NCI E-064-2008-2-AT-07 Epoxy-Guaiane Derivatives And Treatment of Cancer AT EP 08869946.7 Issued
NCI E-064-2008-2-BE-08 Epoxy-Guaiane Derivatives And Treatment of Cancer BE EP 08869946.7 Issued
NCI E-064-2008-2-LU-17 Epoxy-Guaiane Derivatives And Treatment of Cancer LU EP 08869946.7 Issued
NCI E-064-2008-2-IE-15 Epoxy-Guaiane Derivatives And Treatment of Cancer IE EP 08869946.7 Issued
NCI E-064-2008-2-IT-16 Epoxy-Guaiane Derivatives And Treatment of Cancer IT EP 08869946.7 Issued
NCI E-064-2008-2-FR-13 Epoxy-Guaiane Derivatives And Treatment of Cancer FR EP 08869946.7 Issued
NCI E-064-2008-2-DK-11 Epoxy-Guaiane Derivatives And Treatment of Cancer DK EP 08869946.7 Issued
NCI E-064-2008-2-DE-10 Epoxy-Guaiane Derivatives And Treatment of Cancer DE EP 08869946.7 Issued
NCI E-064-2008-2-ES-12 Epoxy-Guaiane Derivatives And Treatment of Cancer ES EP 08869946.7 Issued
NCI E-064-2008-2-NO-20 Epoxy-Guaiane Derivatives And Treatment of Cancer NO EP 08869946.7 Issued
NCI E-064-2008-2-NL-18 Epoxy-Guaiane Derivatives And Treatment of Cancer NL EP 08869946.7 Issued
NCI E-064-2008-2-GB-14 Epoxy-Guaiane Derivatives And Treatment of Cancer GB EP 08869946.7 Issued
NCI E-064-2008-2-SE-19 Epoxy-Guaiane Derivatives And Treatment of Cancer SE EP 08869946.7 Issued
NCI E-064-2008-2-CH-09 Epoxy-Guaiane Derivatives And Treatment of Cancer CH EP 08869946.7 Issued
NCI E-064-2008-2-PCT-01 Epoxy-guaiane Selective Renal Cancer Inhibitors PCT PCT COMB PCT/US2008/088529 Expired
NIDDK E-109-2006-0-KR-07 ADENOSINE DERIVATIVES, THEIR MANUFACTURING METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT KR National Stage 10-2008-7031811 Issued
NCI E-315-2007-0-PCT-02 Novel Natural Product Inhibitors Of ABCG2 PCT PCT PCT/US2008/088446 Expired
NCI E-325-2008-0-US-01 Survivin Specific T Cell Receptor For Immunotherapy Of Cancer US 61/140,338 Abandoned
NIEHS E-334-2008-0-US-01 Artificial Splicing Factors With PUF Protein RNA-binding Domain And Splicing Effector Domains US 61/140,326 Abandoned
NCI E-154-2009-0-US-01 INHIBITORS OF MRE11, RAD50 AND/OR NBS1 US 61/203,377 Abandoned
NCI E-201-2006-1-US-01 Compositions And Methods For Diagnosis And Treatment of Tumors US CIP 12/340,211 7803380 Abandoned PDF
NIA E-049-2001-0-US-14 GLP-1, Exendin-4 Peptide Analogs and Uses Thereof US CON 12/317,042 8278272 Expired PDF
NCI E-257-2008-0-US-30 Melanoma Associated Peptide Analogues And Vaccines Against Melanoma US CON 12/337,834 7846450 Expired PDF
NICHD E-192-1999-0-JP-08 Determination of an Empirical Statistical Distribution of the Diffusion Tensor In MRI JP DIV 2008-321417 Abandoned
NCI E-071-2009-0-PCT-02 METHODS TO DIAGNOSE AND IMMUNIZE AGAINST THE VIRUS CAUSING HUMAN MERKEL CELL CARCINOMA PCT PCT PCT/US2008/086895 Expired
NIAID E-133-1993-1-US-06 BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS US DIV 12/335,305 Abandoned
NIA E-031-2008-0-US-01 A Bioluminescence Method To Measure Phosphodiesterase Activity US 61/122,056 Abandoned
NINDS E-007-2009-0-US-01 Use Of CD25-blocking Molecules To Target Specific T-cells US 61/201,589 Abandoned
NCI E-180-2008-0-US-01 COMPOSITIONS AND METHODS USEFUL FOR DETECTING AND TREATING DISEASES ASSOCIATED WITH 16P CHROMOSOMAL DISRUPTIONS US 61/121,997 Abandoned
NCI E-106-2005-0-US-03 IDENTIFICATION OF BIOMARKERS BY SERUM PROTEIN PROFILING US National Stage 11/886,886 9075062 Abandoned PDF
NIAID E-133-2011-0-PCT-02 Vaccines Directed Against Adenovirus Serotype 14 PCT PCT PCT/US2008/086452 Expired
NLM E-107-2010-1-US-01 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US 61/121,844 Abandoned
NIAID E-133-2011-0-CA-04 Vaccines Directed Against Adenovirus Serotype 14 CA National Stage 2708367 Abandoned
NIEHS E-009-2009-0-US-01 Inhibition Of Inter-Alpha Trypsin Inhibitor For The Treatment Of Airway Disease. US 61/121,407 Abandoned
NCI E-237-2006-0-US-04 ABCB1 Genotyping To Predict Microtubule-Stabalizing-Agent-Iduced Toxicity US National Stage 12/304,071 8835115 Issued PDF
NCI E-245-1994-0-US-39 CHIMERIC PAPILLOMA VIRUS-LIKE PARTICLES US CON 12/331,368 7691386 Expired PDF